Paula
Rodríguez Otero
Consultora Médica
University Medical Center Freiburg
Friburgo de Brisgovia, AlemaniaPublications in collaboration with researchers from University Medical Center Freiburg (3)
2023
-
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
The Lancet Oncology, Vol. 24, Núm. 6, pp. e255-e269
2022
-
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
European Journal of Haematology, Vol. 108, Núm. 1, pp. 73-83
2017
-
Is immunotherapy here to stay in multiple myeloma?
Haematologica, Vol. 102, Núm. 3, pp. 423-432